CVE-2023-22868

MEDIUMCVSS 5.4/10EPSS 0.40%

Last modified

CVE-2023-22868 is a medium-severity vulnerability rated 5.4/10 on the CVSS scale. IBM Aspera Faspex 4.4.1 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. EPSS estimates a 0.40% chance of exploitation in the next 30 days.

Description

IBM Aspera Faspex 4.4.1 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 244117.

Metrics

CVSS 3.1
5.4/10

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

EPSS Probability
0.40%

32.3th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

VendorProductVersionsUpdate
IbmAspera Faspex<= 4.4.1
IbmAspera Faspex4.4.1Patch Level 1

References

Timeline

Published
Last Modified
Status
Modified

Frequently Asked Questions

What is CVE-2023-22868?
IBM Aspera Faspex 4.4.1 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 244117.
How severe is CVE-2023-22868?
CVE-2023-22868 has a CVSS score of 5.4/10 (MEDIUM severity). The EPSS model estimates a 0.40% probability of exploitation in the next 30 days.
How do I fix CVE-2023-22868?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2023-22868?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST